A Tennessee Valley family gathered together for the 2013 holiday season, and everyone was in good spirits. However, a mere five days later, the family was saddened by the news…
Read More
Karen Langhart never thought she would outlive her daughter. However, due to insufficient drug testing and inadequate medical warnings, NuvaRing caused blood clots, pulmonary embolisms and heart attacks resulting in…
Read More
Women who experienced Yaz side effects involving certain types of blood clot formation, and who filed lawsuits against Yaz and Yasmin manufacturer, Bayer, received good news last month. The federal…
Read More
The Langhart parents were expecting their daughter, Erika, to fly home for Thanksgiving. Instead, they got a call summoning them to a Virginia hospital, because their daughter had suffered multiple…
Read More
August 15, 2009 – Boehringer Ingelheim researchers submitted Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial data to The New England Journal of Medicine October 19, 2010 – Pradaxa approved…
Read More
The NuvaRing mass tort in New Jersey recently convened on June 19, 2013 for a case management conference amid news that the first NuvaRing lawsuit consolidated into the mass tort…
Read More
According to a recent Madison-St. Clair Record article, NuvaRing lawsuits have recently been filed in the U.S. District Court for the Southern District of Illinois charging five defendants, among them…
Read More
The U.S. Food and Drug Administration (FDA) recently approved a reversal agent to be used in patients experiencing serious and uncontrollable bleeding. The anticoagulation reversal agent is called Kcentra, a…
Read More
The blood thinner medication known as Pradaxa is currently under scrutiny, as the drug has been known to cause severe bleeding, sometimes resulting in death. Pradaxa is a drug manufactured…
Read More
Published June 20, 2012 on LawsuitInformation.org The FDA recently mandated that Bayer Pharmaceuticals change the warning labels on two of its most popular birth control pills to reflect recent research…
Read More